{"id":969699,"date":"2026-06-02T16:04:53","date_gmt":"2026-06-02T20:04:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/"},"modified":"2026-06-02T16:04:53","modified_gmt":"2026-06-02T20:04:53","slug":"ibio-to-participate-in-upcoming-healthcare-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/","title":{"rendered":"iBio to Participate in Upcoming Healthcare Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, June  02, 2026  (GLOBE NEWSWIRE) &#8212; iBio, Inc. (<strong>NASDAQ: IBIO<\/strong>) (\u201ciBio\u201d or the \u201cCompany\u201d), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference and the Leerink Partners Therapeutics Forum: I&amp;I and Metabolism Conference.<\/p>\n<p>\n        <strong>Jefferies Global Healthcare Conference<\/strong><br \/>\n        <br \/>\n        <u>Presentation Date<\/u>: Thursday, June 4, 2026<br \/><u>Time<\/u>: 11:40 a.m. ET<br \/><u>Location<\/u>: Marriott Marquis, New York<\/p>\n<p>A livestream of the event can be accessed\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=44NU4H82NKpBx3ePk2iSZwYJcnCV1HLvm6rJ7Z3z50DHI3l9UhFXbQifJKLdV0I4HPahkoh6zHOJezITEUw_YPeLNE9bIepjzvfp_CqzDYzJLDrSuN_vCzFbze6SM8RuL43VuJoMWRWjvzcXoF48BcAeyctdDM8RKQT4Uu17Tq-jorV5_CeHZl7g44pU7tN1\" rel=\"nofollow\" target=\"_blank\">link<\/a>, and a replay of the presentation webcast will be available on the Investor Relations section of the iBio website for 90 days following the event.<\/p>\n<p>\n        <strong>Leerink Partners Therapeutics Forum: I&amp;I and Metabolism<\/strong><br \/>\n        <br \/>\n        <u>Event Dates<\/u>: July 14\u201315, 2026<br \/><u>Location<\/u>: Boston Harbor Hotel, Boston<\/p>\n<p>Dr. Brenner and Mr. Duran will participate in one-on-one investor meetings during the Leerink conference. Preliminary meeting schedules are expected to be available in mid-June.<\/p>\n<p>To request a meeting with Dr. Brenner or Mr. Duran at either conference, please contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VFVA7RDpWyAEzdJtf8XaWtH8ILxv3SNWe4Kpi9ksvHJaw21y_8iGAu5w30MdagteDqea1j_Cpf9_P4DPP0WEEg==\" rel=\"nofollow\" target=\"_blank\">ir@ibioinc.com<\/a>.<\/p>\n<p>\n        <strong>About iBio, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>iBio\u00a0<\/strong>(Nasdaq: IBIO) is a clinical-stage biotechnology developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, cancer, and other hard-to-treat diseases. Combining advanced antibody engineering with AI-driven discovery, iBio is advancing a differentiated pipeline designed to deliver sustained therapeutic effects and address significant unmet medical needs. iBio\u2019s mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8u1_ebxm6JXzmCvqHXN77fo22e11nI3o2EAJT5ZOqBQKQkkOQn3VyEYxbzVzYZpR2ltpC4g8pT3MNscso03ce4ue62iyrucqOlDpK7UFVOmOOpSWsk-nvr62LeoR2ojSnPhxTxYdqjL3i9vG0hCd-q_dDWQRjG9RtvyYCCGbnCStp2-oqqIglAP643y-2vF6QABjn6mnSBfpLUHJphInZhTZd-Uny_j3YuibVeET9D9wQCKcScSSZCXcvsInhqWWPNTxzMwk_p6kUHfP0QVj_YjULx1fqWEN-ePUF9iXIhfmFEMT5kaBbffA6m-K7hfyd6LzdaBFg3lfIznnTIW_fOPRSgLSl5HlMlkOuAWzVCezhOfzVDpYfcGRfSoKjmQCnYj6iHJI5UOMkYsn_HdaOYaGLiESG1b7q0pkCLTeeShS9Pk4dEBte1UkLYmUXvQYG7HhLWgWry34qQRhk27uvdgzfQVsm01EFiIzMuKSwC-GuKmKFHCLkBbdgPbbU8pfUY2Hg_474kWuJ7q8EubmBCRakubEYkjrf8kbuHQCp0oXG1I8GH84Tkyq622pM5ZKIdYqA6wBUuV3yBlZseWzkI-2Rn0Sj7BQ9Ev1U1_tekDyhDPwrkVIJ49lluoUDAzp7qTxuqmhhzeXSs0LM0CsYBjhy9vSC1H_LziRAbWmrWd_RasX0vLFxsc-wDEGeJJiHAVtvDGB8K1neM0rwTeL0w==\" rel=\"nofollow\" target=\"_blank\">www.ibioinc.com<\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pSInLWRdgPaneKZNxstNIhvf4tcvuAeR__xAXChSVgV8hbOVTLLxO4SGAiAwJstcbMnyomc_Hts2xklg1AArlMJ9AX1KeukuHiJrSOSfbkGN-4zSIBJCQGYZ_c5H5Wo0MSQZjGZKdu0lzYnpWfg8uycGRfhQggmJUHqwOH8EggB8ot_5WhTQaJo1w1hUuI2UAuENl1Fx9Q_3JE8YM-gqN_6yX276SZXjzccg-tcPj6-HrdYF8-jS4bKxtgNRWpku0LkVqgRUq_P64CsiyW_ByqvSb0TnUl73zvjv0aKJT7M8FBf8UpeFIPcivZYnoT5vy1LJxuO4HVnwrLa1JZ--_K8jNS34qt5qeLvoqfW7YBgE-O8PXorK9UyyABPh11hRK88W1M5YCfBaPif460BZZqm5vjAeD4zCqkFq3MY-cYYjgFt92TkRQ97WNb20-FrSPBV7GMafwT0XoCtaQR4G6fVCJnLY0XTN4cTDGtwBZWQ3XHpGPXnzOS2h_XyULrnQjKQQzJh3-bAtbEwefGszSNiEkzoSvITxR_gqzMKea2wfoBDAQBhOynTBvrKm2AzpRFojFJ3c2VI5EVeAziCGlgC3sFSMLLq07NlX3wJtlgrlfrpCEL7kXR51ROua7GQY2PfExnm6RTrbgmVb19UAcCyncVKe2a_LaI-f6zoT2yKH6TQVCKTUEF-Az3qQkR74dCNURdRb8j0lNX6XO9JAWcdVBiOnJMvi2BxCALu80mJvpgVF73qLcVqNAMZUQpdd\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>iBio, Inc.\u00a0<br \/>Investor Relations\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VFVA7RDpWyAEzdJtf8XaWseVy0fp1STg05j0xXh8FDXTmrSCOBMFF45l6GVuRHe2tqfhX27a2m6xdOnTkIVe2Q==\" rel=\"nofollow\" target=\"_blank\">ir@ibioinc.com<\/a><\/p>\n<p>Ignacio Guerrero-Ros, Ph.D., or David Schull<br \/>Russo Partners, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rLz1Cn_bcC45cdNvq5-MR_Rb0DncfvuDJL2qmWgF_arFNVHqyq7JVRT_RSYftRofBP1dSFP3FL3thV7Fw_OxG5gbFVhAeg1Cv_vhDxpFLNTwoD37JMeiONmYorgab1z5B5kA2PIrQ8jnEEYrlYd41d-kHO18jm9Ea1Ltfgfprxg=\" rel=\"nofollow\" target=\"_blank\">Ignacio.guerrero-ros@russopartnersllc.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MJj_L_JRBYdig6XLSlLVU6gGRsHcffwOvWK8muF9oL1CATJ0ubaj4YiLW_d5TkSeYJwS01SIzdlm28BSokjT2lrEn34DGJTPzR62hqtL9PFMjqB8jFCi3u0YxsoiwagYuExf6w0scQLAGP0uLHLNlQNc3kNcrzOlZN2GaqGhHjm7RByUJK21UoNFJmpPd-el8ZxN0W5QXh-9UG5fOgXs_oSgAsmKQBhHV_c7sf6W73dYqrJfAQ_6MiroAkp4T11keRIsZiZ7Bqu5oTZS2yc_Slmb6h0WedqBFg4SLx4f5G3oA0AQLLg04p5bGP2vObUsLjntmvoAIM9AFPDrztU_M_FjxZmyL20qIybQV4xr_AJLiCsw8ypAGhyEKTZa1bPA8HUoO87L_Wa_a7qNV-Z-EhLckssEnDyxWHj-ATv550XKLGISvKNvdP5HvvNwdfwyt4YVKcN289TmX_fOakkB0K-i8Q7v7YzgoIj16qZRGeWyJgpv2lKIcgFUr6jbII61JT-HKa54GEmEGz-jwbrp5-H0im3oh6ZjrB3rr2VCrto=\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RabWJYuXCwl9ls0-B6Xke2P_xTTruiX7lKjeevFZEjjjW5u3pQz2l68IL8o8h_Kjzo6Lj0oePwo9Of6hzJBJ2nr85sk4Khnmqp5JhkhHkp-8r-zfT1WrXVxmFZq79eaBE80HaEsDwLmO2J173jOaIg==\" rel=\"nofollow\" target=\"_blank\">David.schull@russopartnersllc.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qrvtKsu_SQ5dNtp9otFpLr4Ku2PbwvaQ5aE_fw339wYDYMyGaLdi95AV1bsrJPrxORS4ZG4_QPAO0guET9BCvS7wKnFghJGpFQG4DZByOecQWx4aUF7PASeF21X1r5POek0WPJ1kru8YArh64Jv5GRC_1LFLR2dgsaa7_8qONVZyQfWgQVUjmn1EiwEJlKLzWo5oW7pRJCQG9muwBImhGejs5M1sN97wNLHnqBGcEhX-lEKErYI_wehWmPG8X_fIWmnM2oluGP-0PUQcPgNHxn-Xv1VdCGFtyBq3FqOuPTz7sSkHQS2Ll4A5TbDLROuxvB_9PISxjTgYfB8RwHbf1BbOHhnF2G0C29QJ8mkxgspGmAjqXUpH6NyFHvrWTN7i-55dGEeU8ov0BCrX8pe8yYgDK7hnHwGwze5xJwcO705AQ_YBOmPeb84pV_BlJe-JSk4t0rcZH0HW8NiiEpZ-14H4WwChxWNQf59tHI0SXwA4QT2hTznqaI10zdwQ3Iv0\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a>(858) 717-2310 or (646) 942-5604<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTQ1YjVhNGMtYjBlNC00NzFhLWE3NDAtMTU2NTEzOGYzZWE2LTEwOTkxNDQtMjAyNi0wNi0wMi1lbg==\/tiny\/iBio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) &#8212; iBio, Inc. (NASDAQ: IBIO) (\u201ciBio\u201d or the \u201cCompany\u201d), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference and the Leerink Partners Therapeutics Forum: I&amp;I and Metabolism Conference. Jefferies Global Healthcare Conference Presentation Date: Thursday, June 4, 2026Time: 11:40 a.m. ETLocation: Marriott Marquis, New York A livestream of the event can be accessed\u00a0link, and a replay of the presentation webcast will be available on the Investor Relations section of the iBio website for 90 days following the event. Leerink Partners Therapeutics Forum: I&amp;I &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;iBio to Participate in Upcoming Healthcare Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-969699","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>iBio to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iBio to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) &#8212; iBio, Inc. (NASDAQ: IBIO) (\u201ciBio\u201d or the \u201cCompany\u201d), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference and the Leerink Partners Therapeutics Forum: I&amp;I and Metabolism Conference. Jefferies Global Healthcare Conference Presentation Date: Thursday, June 4, 2026Time: 11:40 a.m. ETLocation: Marriott Marquis, New York A livestream of the event can be accessed\u00a0link, and a replay of the presentation webcast will be available on the Investor Relations section of the iBio website for 90 days following the event. Leerink Partners Therapeutics Forum: I&amp;I &hellip; Continue reading &quot;iBio to Participate in Upcoming Healthcare Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T20:04:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"iBio to Participate in Upcoming Healthcare Investor Conferences\",\"datePublished\":\"2026-06-02T20:04:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/\"},\"wordCount\":292,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/\",\"name\":\"iBio to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=\",\"datePublished\":\"2026-06-02T20:04:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iBio to Participate in Upcoming Healthcare Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iBio to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"iBio to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, June 02, 2026 (GLOBE NEWSWIRE) &#8212; iBio, Inc. (NASDAQ: IBIO) (\u201ciBio\u201d or the \u201cCompany\u201d), an AI-driven innovator developing therapies for cardiometabolic, obesity and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference and the Leerink Partners Therapeutics Forum: I&amp;I and Metabolism Conference. Jefferies Global Healthcare Conference Presentation Date: Thursday, June 4, 2026Time: 11:40 a.m. ETLocation: Marriott Marquis, New York A livestream of the event can be accessed\u00a0link, and a replay of the presentation webcast will be available on the Investor Relations section of the iBio website for 90 days following the event. Leerink Partners Therapeutics Forum: I&amp;I &hellip; Continue reading \"iBio to Participate in Upcoming Healthcare Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-02T20:04:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"iBio to Participate in Upcoming Healthcare Investor Conferences","datePublished":"2026-06-02T20:04:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/"},"wordCount":292,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/","name":"iBio to Participate in Upcoming Healthcare Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=","datePublished":"2026-06-02T20:04:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMDE1OSM3NjMxNzUyIzIwODc1NzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ibio-to-participate-in-upcoming-healthcare-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"iBio to Participate in Upcoming Healthcare Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=969699"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969699\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=969699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=969699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=969699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}